Get Our Top Trade Ideas Delivered Daily - 65% Off Now

+ New Watchlist

Benzinga Research

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Seelos Therapeutics

SEELNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.331800

0.1474.63%

Last update: 1:19 PM

15 minutes delayed

Why is it moving?

Seelos Therapeutics shares are trading higher after the company announced it signed a material transfer agreement to supply SLS-002 for the Department of Defense's military and veterans adaptive platform clinical trial for PTSD.

Seelos Therapeutics (SEEL) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Seelos Therapeutics (NASDAQ:SEEL) Stock

Seelos Therapeutics Stock (NASDAQ: SEEL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, September 24, 2024

Nasdaq Surges 100 Points; Thor Industries Earnings Top Views
Avi Kapoor
Dow Rises Over 50 Points; AutoZone Posts Downbeat Earnings
Avi Kapoor
Seelos Therapeutics shares are trading higher...
Benzinga Newsdesk
Seelos Therapeutics Signs Material Transfer A...
Benzinga Newsdesk

Monday, September 23, 2024

'DEA Calls For Massive Increases In Psilocybi...
Benzinga Newsdesk

Monday, August 19, 2024

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor

Friday, August 16, 2024

US Stocks Edge Lower; Applied Materials Earnings Top Views
Avi Kapoor
Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Wednesday, July 31, 2024

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Javier Hasse

Friday, July 26, 2024

Seelos Therapeutics Announces Nasdaq Panel Gr...
Benzinga Newsdesk

Tuesday, July 16, 2024

'MDMA Therapy Gets Support From Prominent Res...
Benzinga Newsdesk

Wednesday, July 10, 2024

Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Wednesday, June 12, 2024

'Oregon's First-In-Nation Psilocybin Industry...
Benzinga Newsdesk

Friday, June 07, 2024

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Friday, May 17, 2024

Seelos Therapeutics Prices $1.1M Registered D...
Benzinga Newsdesk

Wednesday, May 15, 2024

Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Seelos Therapeutics shares are trading higher...
Benzinga Newsdesk

Tuesday, May 14, 2024

Seelos Therapeutics Approves 1-For-8 Reverse ...
Benzinga Newsdesk

Tuesday, May 07, 2024

"FDA Expert Committee Will Review MDMA-Assist...
Benzinga Newsdesk

Friday, May 03, 2024

On April 30, Seelos Therapeutics Inc Announc...
Benzinga Newsdesk

Monday, April 29, 2024

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Seelos Therapeutics Announces Strategic Focus...
Benzinga Newsdesk

Wednesday, March 20, 2024

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights

Tuesday, March 19, 2024

Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results
Avi Kapoor
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
Avi Kapoor
Nasdaq Down 100 Points; US Housing Starts Surge In February
Avi Kapoor
CNS Disorder-Focused Seelos Therapeutics Plunges To 52-Week Low - Here's Why
Vandana Singh
Seelos Therapeutics shares are trading lower ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Seelos Therapeutics Says The Study Did Not Me...
Benzinga Newsdesk
Seelos Therapeutics Provides Update On Top-Li...
Benzinga Newsdesk

Thursday, March 14, 2024

Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk

Thursday, February 15, 2024

Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein

Monday, February 12, 2024

'FDA Grants Priority Review Of MDMA-Assisted ...
Benzinga Newsdesk

Saturday, January 27, 2024

Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein

Friday, January 26, 2024

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein
Seelos Therapeutics Announces $4M Registered ...
Benzinga Newsdesk

Monday, January 22, 2024

Seelos Therapeutics Announces Receipt Of Minu...
Benzinga Newsdesk

Friday, January 12, 2024

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights

Thursday, January 11, 2024

Seelos Therapeutics Filed U.S. Patent Application #20240009113 : Treatment Of Protein Aggregation Myopathic And Neurodegenerative Diseases By Parenteral Administration Of Trehalose
Charles Gross

Monday, January 08, 2024

Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And More
Lara Goldstein
'New Bipartisan Washington Bill Would Legaliz...
Benzinga Newsdesk

Thursday, January 04, 2024

"DEA Confirms That Psychedelic Mushroom Spore...
Benzinga Newsdesk

Wednesday, December 27, 2023

Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein

Friday, December 22, 2023

Seelos Therapeutics Released A Letter To Its ...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved